Upgrade to premium to see the full reasoning behind each conviction change.
Sign in to unlockFair Value Distribution — percentile bands
19.0% of simulations place fair value above current price
WHAT IS PRICED IN
Revenue-Based Reverse DCF
15.0%/yr
±3.5% · revenue growth to justify current price
FCF-Based Reverse DCF
21.8%/yr
±3.2% · FCF growth to justify current price
THE GAP
Market pricing margin compression or rising capex
Upgrade to premium for full distribution data, sensitivity analysis, and segment breakdowns.
Sign in to unlockAzure reaccelerating at +39% with RPO at $625B — the backlog alone is larger than most tech companies' revenue. Copilot monetization just starting across Office 365's 400M+ seat base. OpenAI partnership gives MSFT the most defensible AI distribution moat in enterprise software.
Down 17% in 3 months from war-deleveraging — macro headwinds are real and MSFT trades as a risk asset now. $80B+ annual capex on AI infrastructure needs to generate returns; if Copilot uptake disappoints, the capex looks like overinvestment. Antitrust risk from EU and DOJ on cloud bundling.
Azure growth below 30%, Copilot churn above 20%, antitrust forced unbundling
Updated Mar 11
MSFT -26% YTD despite strong growth — market questioning whether AI CapEx ($110-120B FY26) will ROI. Stock trying to recover from weak 2026 start. Earnings April 28 will be critical test. Analyst avg ...
MSFT confirmed -22% YTD with HR restructuring news adding pressure. Q2 FY2026: revenue .3B (+17%), Azure +39%, but CapEx surged 66% to .5B/quarter with B projected for full FY2026. Market questioning ...
MSFT down 20% YTD, worst Mag-7 performer. Market pricing in risk that AI software makes MSFT enterprise suite obsolete. Azure +39% growth is real but sentiment overwhelmingly negative. April 29 earnin...
Azure +39-40% confirms AI demand. Commercial RPO +110% to 625B signals enterprise AI cloud scale commitments. 47% operating margin with 17-18% revenue growth. CapEx surge (49.3B H1) compressed FCF but...
Azure reaccelerated to 39%, commercial RPO surged 110% to $625B, and operating margin expanded to 47%. GAAP EPS was massively inflated by a $10B OpenAI dilution gain. Adjusted EPS +24%. CapEx intensit...